• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

兔肢体淋巴中的止血因子:与调节血管外凝血机制的关系

Hemostatic factors in rabbit limb lymph: relationship to mechanisms regulating extravascular coagulation.

作者信息

Le D T, Borgs P, Toneff T W, Witte M H, Rapaport S I

机构信息

Department of Pathology, University of California, San Diego, La Jolla 92093-0612, USA.

出版信息

Am J Physiol. 1998 Mar;274(3):H769-76. doi: 10.1152/ajpheart.1998.274.3.H769.

DOI:10.1152/ajpheart.1998.274.3.H769
PMID:9530187
Abstract

Mechanisms regulating extravascular coagulation in interstitial fluids of peripheral tissues are poorly understood, since measurements of hemostatic factors in these fluids are unavailable. Because lymph from a body region reflects the composition of its interstitial fluid, we measured hemostatic factors in limb lymph of rabbits both as activity and as antigen. Mean lymph-to-plasma activity ratios were the following: fibrinogen, 0.28; prothrombin, 0.26; factor X, 0.27; factor VII, 0.17; and factors V and VIII, 0.08. All lymph fibrinogen was clottable; fibrin degradation products were absent. Lymph von Willebrand factor antigen was < 10% of plasma antigen and consisted primarily of lower molecular weight multimers. Mean lymph-to-plasma activity ratio for antithrombin was 0.38 and for tissue factor pathway inhibitor the ratio was 0.40. Low levels of antithrombin-factor Xa were measurable in lymph. The data are compatible with a basal factor VIIa-tissue factor-catalyzed extravascular activation of factor X that is prevented from progressing to generation of fibrin in limb interstitial fluid and lymph by low levels of factor VIII and factor V and by the inhibitory activity of antithrombin and tissue factor pathway inhibitor.

摘要

由于无法测量外周组织间质液中的止血因子,调节外周组织间质液血管外凝血的机制目前仍知之甚少。由于来自身体某一区域的淋巴液反映了其间质液的成分,我们对兔肢体淋巴液中的止血因子进行了活性和抗原测定。淋巴液与血浆的平均活性比值如下:纤维蛋白原,0.28;凝血酶原,0.26;因子X,0.27;因子VII,0.17;因子V和因子VIII,0.08。所有淋巴纤维蛋白原均可凝;不存在纤维蛋白降解产物。淋巴血管性血友病因子抗原低于血浆抗原的10%,主要由低分子量多聚体组成。抗凝血酶的淋巴液与血浆平均活性比值为0.38,组织因子途径抑制物的比值为0.40。淋巴液中可检测到低水平的抗凝血酶-因子Xa。这些数据与因子VIIa-组织因子催化的因子X血管外激活相一致,在肢体间质液和淋巴液中,由于因子VIII和因子V水平较低以及抗凝血酶和组织因子途径抑制物的抑制活性,该激活过程无法进展为纤维蛋白的生成。

相似文献

1
Hemostatic factors in rabbit limb lymph: relationship to mechanisms regulating extravascular coagulation.兔肢体淋巴中的止血因子:与调节血管外凝血机制的关系
Am J Physiol. 1998 Mar;274(3):H769-76. doi: 10.1152/ajpheart.1998.274.3.H769.
2
Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.纤维蛋白凝块的形成:促凝血因子与抑制因子的平衡。
Clin Haematol. 1985 Jun;14(2):281-342.
3
Chromatography of human plasma on aminohexyl Sepharose: separation of factor VIII/vWf and behaviour of factors II, VII, IX and X and antithrombin III.
J Chromatogr. 1989 Jul 21;491(2):299-308. doi: 10.1016/s0378-4347(00)82848-0.
4
Enzyme-linked coagulation assay. II. A sensitive assay for tissue factor and factors II, VII, and X.酶联凝血测定法。II. 组织因子以及因子II、VII和X的灵敏测定法。
Anal Biochem. 1986 Jan;152(1):199-207. doi: 10.1016/0003-2697(86)90141-7.
5
Coagulation abnormalities following intensive plasma exchange on the cell separator. II. Effects on factors I, II, V, VII, VIII, IX, X and antithrombin III.血细胞分离机上进行强化血浆置换后的凝血异常。II. 对因子I、II、V、VII、VIII、IX、X及抗凝血酶III的影响
Br J Haematol. 1981 Aug;48(4):627-34. doi: 10.1111/j.1365-2141.1981.00627.x.
6
Synthetic peptide substrate assays for hemostasis testing.用于止血测试的合成肽底物分析
Adv Clin Chem. 1986;25:117-68. doi: 10.1016/s0065-2423(08)60125-0.
7
Coagulant proteins and thrombin generation in synovial fluid: a model for extravascular coagulation.滑液中的凝血蛋白与凝血酶生成:一种血管外凝血模型
Am J Hematol. 1995 Oct;50(2):79-83. doi: 10.1002/ajh.2830500202.
8
Blood coagulation values of sheep.绵羊的血液凝固值。
Am J Vet Res. 1971 Mar;32(3):405-9.
9
Coagulation properties of human thoracic duct lymph.
Am J Med Sci. 1967 Jan;253(1):69-75. doi: 10.1097/00000441-196701000-00013.
10
Cardiopulmonary bypass. Associated hemostatic abnormalities.体外循环。相关的止血异常。
J Thorac Cardiovasc Surg. 1979 Mar;77(3):427-35.

引用本文的文献

1
Lymphatic coagulation and neutrophil extracellular traps in lung-draining lymph nodes of COVID-19 decedents.COVID-19 逝者肺引流淋巴结中的淋巴凝结和中性粒细胞细胞外陷阱。
Blood Adv. 2022 Dec 27;6(24):6249-6262. doi: 10.1182/bloodadvances.2022007798.
2
Coagulation in Lymphatic System.淋巴系统中的凝血
Front Cardiovasc Med. 2021 Nov 24;8:762648. doi: 10.3389/fcvm.2021.762648. eCollection 2021.
3
Postoperative care after lymphaticovenous anastomosis.淋巴管静脉吻合术后的护理
Arch Plast Surg. 2021 May;48(3):333-335. doi: 10.5999/aps.2019.01004. Epub 2021 May 15.
4
Transcriptional landscape of pulmonary lymphatic endothelial cells during fetal gestation.胎儿发育过程中肺淋巴管内皮细胞的转录组图谱。
PLoS One. 2019 May 13;14(5):e0216795. doi: 10.1371/journal.pone.0216795. eCollection 2019.
5
Absence of functional compensation between coagulation factor VIII and plasminogen in double-knockout mice.双重基因敲除小鼠凝血因子 VIII 和纤溶酶原之间不存在功能代偿。
Blood Adv. 2018 Nov 27;2(22):3126-3136. doi: 10.1182/bloodadvances.2018024851.
6
Evaluation of Lymphorrhea and Incidence of Lymphoceles: 4DryField® PH in Radical Retropubic Prostatectomy.淋巴漏及淋巴囊肿发生率的评估:耻骨后根治性前列腺切除术中的4DryField® PH
Adv Urol. 2016;2016:2367432. doi: 10.1155/2016/2367432. Epub 2016 Jun 23.
7
Patterns of expression of factor VIII and von Willebrand factor by endothelial cell subsets in vivo.体内内皮细胞亚群中因子VIII和血管性血友病因子的表达模式
Blood. 2016 Jul 7;128(1):104-9. doi: 10.1182/blood-2015-12-684688. Epub 2016 May 12.
8
Cross-transfusion of postshock mesenteric lymph provokes acute lung injury.休克后肠系膜淋巴液的交叉输注会引发急性肺损伤。
J Surg Res. 2011 Oct;170(2):314-8. doi: 10.1016/j.jss.2011.03.045. Epub 2011 Apr 17.
9
CD8+ T cell concentration determines their efficiency in killing cognate antigen-expressing syngeneic mammalian cells in vitro and in mouse tissues.CD8+ T 细胞浓度决定了它们在体外杀伤同种抗原表达的同源哺乳动物细胞和在小鼠组织中的效率。
J Exp Med. 2010 Jan 18;207(1):223-35. doi: 10.1084/jem.20091279. Epub 2010 Jan 11.
10
Bio-distribution of pharmacologically administered recombinant factor VIIa (rFVIIa).药物管理的重组因子 VIIa(rFVIIa)的生物分布。
J Thromb Haemost. 2010 Feb;8(2):301-10. doi: 10.1111/j.1538-7836.2009.03696.x. Epub 2009 Nov 23.